Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 264

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

An updated catalog of prostate cancer predictive tools

Shariat, Shahrokh F., Karakiewicz, Pierre I., Roehrborn, Claus G., Kattan, Michael W. · 2008 · Cancer

Abstract

Accurate estimates of risk are essential for physicians if they are to recommend a specific management to patients with prostate cancer. Accurate risk estimates also are required for clinical trial design to ensure that homogeneous, high‐risk patient groups are used to investigate new cancer therapeutics. Using the MEDLINE database, a literature search was performed on prostate cancer predictive tools from January 1966 to July 2007. The authors recorded input variables, the prediction form, the number of patients used to develop prediction tools, the outcome being predicted, prediction tool‐specific features, predictive accuracy, and whether validation was performed. Each prediction tool was classified into patient clinical disease state and the outcome being predicted. First, the authors described the criteria for evaluation (predictive accuracy, calibration, generalizability, head‐to‐head comparison, and level of complexity) and the limitations of current predictive tools. The literature search generated 109 published prediction tools, including only 68 that had undergone validation. An increasing number of predictive tools addressed important endpoints, such as disease recurrence, metastasis, and survival. Despite their limitations and the limitations of data, predictive tools are essential for individualized, evidence‐based medical decision making. Moreover, the authors recommend wider adoption of risk‐prediction models in the design and implementation of clinical trials. Among prediction tools, nomograms provide superior, individualized, disease‐related risk estimations that facilitate management‐related decisions. Nevertheless, many more predictive tools, comparisons between them, and improvements to existing tools are needed. Cancer 2008. © 2008 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.23908

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Cited by

See all 264

Metadata

Authors
Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G., & Kattan, M. W.
Venue
Cancer
Publisher
Wiley
Published
2008-09-29
Volume
113
Issue
11
Pages
3075-3099
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2057672608
Cited by
264
References
97
FWCI
17.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An updated catalog of prostate cancer predictive tools. https://app.cochat.ai/papers/10.1002/cncr.23908
The paper
Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G., & Kattan, M. W. (2008). An updated catalog of prostate cancer predictive tools. Cancer. https://doi.org/10.1002/cncr.23908

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.